Dr. Richy Agajanian, MD
Claim this profileInnovative Clinical Research Institute
Studies Lymphoma
Studies Non-Small Cell Lung Cancer
13 reported clinical trials
20 drugs studied
Area of expertise
1Lymphoma
Stage II
Stage I
2Non-Small Cell Lung Cancer
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Richy Agajanian, MD is currently running
Pirtobrutinib vs Ibrutinib
for Chronic Lymphocytic Leukemia
The purpose of Part 1 of this study is to compare the efficacy and safety of pirtobruitinib (LOXO-305) to ibrutinib in participants with CLL/SLL; participants may or may not have already had treatment for their cancer. The purpose of Part 2 of this study evaluates pirtobrutinib monotherapy in treatment-naïve participants with CLL/SLL with 17p deletions. Participation could last up to six years for Part 1. Participation could last up to 2 years for Part 2.
Recruiting2 awards Phase 3
Glufosfamide vs Fluorouracil
for Pancreatic Cancer
This trial is testing if the chemotherapy drug glufosfamide can help people with advanced pancreatic cancer live longer. These patients have already tried another treatment called gemcitabine, which didn't work for them. Glufosfamide aims to stop cancer cells from growing by damaging their DNA.
Recruiting3 awards Phase 39 criteria
More about Richy Agajanian, MD
Clinical Trial Related9 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Richy Agajanian, MD has experience with
- Pirtobrutinib
- Pembrolizumab
- PD-1 Inhibitor
- Vodobatinib (K0706)
- HMPL-523
- Rituximab
Breakdown of trials Richy Agajanian, MD has run
Non-Small Cell Lung Cancer
Mixed-Cell Lymphoma
Chronic Lymphocytic Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Richy Agajanian, MD specialize in?
Richy Agajanian, MD focuses on Lymphoma and Non-Small Cell Lung Cancer. In particular, much of their work with Lymphoma has involved Stage II patients, or patients who are Stage I.
Is Richy Agajanian, MD currently recruiting for clinical trials?
Yes, Richy Agajanian, MD is currently recruiting for 2 clinical trials in Downey California. If you're interested in participating, you should apply.
Are there any treatments that Richy Agajanian, MD has studied deeply?
Yes, Richy Agajanian, MD has studied treatments such as Pirtobrutinib, Pembrolizumab, PD-1 inhibitor.
What is the best way to schedule an appointment with Richy Agajanian, MD?
Apply for one of the trials that Richy Agajanian, MD is conducting.
What is the office address of Richy Agajanian, MD?
The office of Richy Agajanian, MD is located at: Innovative Clinical Research Institute, Downey, California 90241 United States. This is the address for their practice at the Innovative Clinical Research Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.